What is Esomeprazole?

Esomeprazole is the S-enantiomer of omeprazole, belonging to the benzimidazole class of proton pump inhibitors. Chemically, it is designated as (S)-5-Methoxy-2-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl-1H-benzimidazole. The compound is a substituted benzimidazole with a molecular formula of C17H19N3O3S and a molecular weight of 345.42 g/mol.

Unlike its racemic parent compound omeprazole, esomeprazole consists specifically of the (S)-enantiomer, which demonstrates improved bioavailability and more consistent pharmacokinetic profiles compared to the racemic mixture.

Chemical Properties of Esomeprazole

Номер CAS	119141-88-7
Молекулярная формула	C17H19N3O3S
Молекулярная масса	345.42 g/mol
Внешний вид	Кристаллический порошок от белого до небелого цвета
Растворимость	Soluble in methanol and DMSO; slightly soluble in water
pKa	9.0 (benzimidazole nitrogen)
Температура плавления	155-160C

Structural Classification

Esomeprazole is classified as a substituted benzimidazole, a group of compounds characterized by a benzimidazole core structure with various substituents.

Механизм действия

Esomeprazole works by irreversibly inhibiting the gastric H+/K+-ATPase enzyme, which is responsible for the final step of gastric acid secretion in parietal cells of the stomach.

1. Pro-drug activation: Esomeprazole is a pro-drug that requires activation in the acidic environment of the parietal cell canaliculi.
2. Covalent binding: The activated form forms covalent disulfide bonds with cysteine residues on the H+/K+-ATPase enzyme.
3. Prolonged inhibition: This irreversible binding inhibits acid secretion until new proton pumps are synthesized, providing up to 24 hours of acid suppression.

Therapeutic Uses and Benefits

Esomeprazole is FDA-approved for the treatment of multiple gastrointestinal conditions:

• Gastroesophageal Reflux Disease (GERD): Treatment of erosive esophagitis
• Duodenal Ulcer: Healing and prevention of recurrence
• Gastric Ulcer: Treatment of benign gastric ulcers
• NSAID-induced Ulcers: Prevention of gastric ulcers
• Zollinger-Ellison Syndrome: Management of gastric acid hypersecretion
• Helicobacter pylori Eradication: As part of combination therapy

Clinical Benefits

• Rapid onset of action: Begins suppressing acid within 1 hour
• Long-lasting effect: Single daily dosing provides 24-hour acid control
• Superior efficacy: Better acid control than omeprazole
• Improved healing rates: Higher rates of erosive esophagitis healing

Дозировка и применение

Condition	Recommended Dose	Duration
GERD/Erosive Esophagitis	20-40 mg once daily	4-8 weeks
Duodenal Ulcer	20 mg once daily	2-4 weeks
Gastric Ulcer	20-40 mg once daily	4-8 weeks
H. pylori Eradication	20-40 mg twice daily	10-14 days

Administration Guidelines

• Take esomeprazole at least 1 hour before meals
• Swallow tablets whole; do not crush or chew
• Can be administered via nasogastric tube if needed

Side Effects and Safety Profile

Common Side Effects

• Headache
• Nausea
• Diarrhea
• Abdominal pain
• Запор
• Flatulence

Less Common Side Effects

• Dizziness
• Dry mouth
• Rash
• Pruritus (itching)

Rare but Serious Considerations

• Long-term use risks: Increased risk of fractures, vitamin B12 deficiency
• Drug interactions: Reduced absorption of ketoconazole, iron salts
• Hypersensitivity reactions: Rare cases of anaphylaxis

Contraindications

• Known hypersensitivity to esomeprazole or omeprazole
• Concomitant use with rilpivirine
• Patients with severe hepatic impairment

Drug Interactions

Interacting Drug	Effect
Clopidogrel	Reduced antiplatelet effect
Atazanavir	Decreased atazanavir levels
Ketoconazole	Reduced antifungal absorption
Iron salts	Reduced iron absorption

Why Choose Esomeprazole?

Advantages Over Other PPIs

1. Higher bioavailability: 50-70% higher plasma concentrations than omeprazole
2. Better acid control: More consistent gastric pH elevation
3. Improved healing rates: Superior healing of erosive esophagitis
4. Faster symptom relief: Quicker resolution of heartburn

Quality Considerations

For pharmaceutical manufacturing or research:

• Purity: 98% minimum for pharmaceutical applications
• cGMP-compliant manufacturing
• Complete COA available
• Reliable supply chain

Frequently Asked Questions

Q: How does esomeprazole differ from omeprazole?

A: Esomeprazole is the S-isomer of omeprazole, providing better bioavailability and more consistent acid suppression.

Q: Can I take esomeprazole with food?

A: Best taken 30-60 minutes before meals for optimal absorption.

Q: How long can I take esomeprazole?

A: Treatment typically lasts 4-8 weeks for GERD. Long-term use requires medical supervision.

Q: Is esomeprazole safe for long-term use?

A: Long-term use may have risks. Regular monitoring by healthcare provider is recommended.

Заключение

Esomeprazole (CAS 119141-88-7) represents a significant advancement in proton pump inhibitor therapy. Its superior pharmacokinetic properties and proven efficacy make it a preferred choice for treating acid-related gastrointestinal disorders.

For pharmaceutical sourcing or bulk supply inquiries, contact us.

---

This article is for informational purposes only and does not constitute medical advice.